Eye imaging study for diabetic retinopathy
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study uses a special eye imaging test called OCT angiography to look at tiny blood vessels in the back of the eye. It aims to understand changes caused by diabetic retinopathy, which could help improve how we monitor and treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with diabetic retinopathy (a diabetes complication affecting the eyes).
- You can have a complete eye exam, including OCT and OCT angiography.
- You have a recent HbA1c blood test result (shows average blood sugar levels).
- You have not had prior vitreoretinal surgery (surgery on the back of the eye).
- You have no other retinal diseases (like retinal vein occlusion) or conditions like glaucoma that could affect the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a detailed eye scan (optical coherence tomography angiography) to look at how blood vessels in the retina are affected. It may help researchers better understand retinal vascular diseases, though some people will be excluded for safety or image-quality reasons.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This study tests a new eye imaging device to see if it can take clear pictures of the back of the eye. It may help doctors better see and monitor conditions like macular degeneration and diabetic retinopathy.
This study uses special eye photographs to look at early signs of diabetes damage in the eyes and kidneys. It may help doctors predict how diabetes complications progress and plan better care.
This study tests whether using a special eye scan (OCTA) to guide targeted laser treatment can slow down the progression of areas with poor blood flow in the retina of people with diabetic retinopathy. The goal is to prevent the condition from getting worse and help preserve your vision.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.